Putting a dollar figure on something that's highly speculative is never easy....and with Resverlogix's Apabetalone I think its even harder than the norm....there are just so many variables.

What's it worth as a treatment for Diabetes patients?  How fast would the take up be assuming its approved?  What are the chances it becomes SOC?

Then the same questions for CKD, Fabry's, Alzheimers and all the rest....

And of course there's the costs of completing BETonMACE and then all the other trial work that need to be factored in....and still there exists the possibility of failure.  

I don't think there's a standard equation anywhere that could take into account the spider web of contingencies and possibilities here. 

Let's just get some news on financing because otherwise there's no point speculating on anything.